Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Ceapro Inc V.CZO

Alternate Symbol(s):  CRPOF

Chemicals Specialty Chemicals
Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human... see more

Recent & Breaking News (TSXV:CZO)

Ceapro Inc. to Present at the Virtual Investor Roundtable Event

GlobeNewswire November 10, 2021

JTC Team to Host Virtual Investor Roundtable Event on November 16th, 17th, and 18th

Accesswire November 4, 2021

Ceapro Inc. to Present at H.C. Wainwright 23rd Annual Global Investment Conference

GlobeNewswire September 8, 2021

Ceapro Inc. Reports 2021 Second Quarter and Six-Month Financial Results and Operational Highlights

GlobeNewswire August 26, 2021

Ceapro (TSXV:CZO) to collaborate with Angiogenesis Foundation

Jocelyn Aspa August 23, 2021

Ceapro Inc. Enters into Research Collaboration with the Angiogenesis Foundation for Beta Glucan and Avenanthramides

GlobeNewswire August 23, 2021

Ceapro (TSXV:CZO) expands collaboration with Montreal Heart Institute in a new clinical study

Julia Kennedy  August 11, 2021

Ceapro Inc. Expands Collaboration with Montreal Heart Institute (MHI) with New Clinical Study Evaluating Flagship Product, Avenanthramide

GlobeNewswire August 11, 2021

Ceapro Announces Results of 2021 Shareholders' Meeting

GlobeNewswire June 1, 2021

Ceapro Inc. Announces Completion of Patient Enrollment in Clinical Study Evaluating Beta Glucan as a Cholesterol-Lowering Agent

GlobeNewswire May 26, 2021

Ceapro Inc. Reports 2021 First Quarter Financial Results and Highlights

GlobeNewswire May 20, 2021

Ceapro Inc. Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights

GlobeNewswire April 22, 2021

Ceapro (TSXV:CZO) completes research and development program with University of Alberta

Trevor Abes  April 8, 2021

Ceapro Inc. Announces Successful Completion of Collaborative Research and Development Program with University of Alberta

GlobeNewswire April 8, 2021

Ceapro Inc. to Present at the H.C. Wainwright Global Life Sciences Conference

GlobeNewswire March 3, 2021

Ceapro Inc. to Present at NobleCon17

GlobeNewswire January 14, 2021

Ceapro Inc. to Present at the H.C. Wainwright BioConnect 2021 Virtual Conference

GlobeNewswire January 8, 2021

Ceapro Inc. Reports 2020 Third Quarter and Nine-Month Financial Results and Operational Highlights

GlobeNewswire November 27, 2020

Ceapro Inc. Announces Increased Financial Contribution from National Research Council of Canada for Innovative PGX Technology Project

GlobeNewswire October 22, 2020

Ceapro Inc. to Present at the H.C. Wainwright 22nd Annual Global Investment Conference

GlobeNewswire September 14, 2020